-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

905. Outcomes Research—Lymphoid Malignancies: Poster III

Symposia: Outcomes Research—Lymphoid Malignancies Program: Oral and Poster Abstracts
Type: Poster
Monday, December 12, 2022: 6:00 PM-8:00 PM
Hall D (Ernest N. Morial Convention Center)

Wenzhen Ge1*, Alexi Archambault1*, Thomas E. Delea, MSIA2*, Karen Rodriguez Lorenc, MD1, James Harnett1*, Aaron Moynahan2*, Derek Weycker, PhD2*, Yariv Houvras, MD, PhD1*, Glenn S. Kroog, MD1*, Ning Wu1*, Christian Hampp1* and Qiufei Ma1*

1Regeneron Pharmaceuticals, Inc., Tarrytown, NY
2Policy Analysis Inc (PAI), Cambridge, MA

Nikhil Yegya-Raman, MD1*, Christopher M. Wright, MD1*, Nicholas B. Figura, MD2*, Siqi Zhang, MS1*, Jessica J. Chew, MD3*, Skyler E. Burke, BS4*, Austin J. Sim, MD, JD2*, Michael J. LaRiviere, MD1*, Jonathan A. Baron, MD1*, Sumi Sinha, MD3*, Joanna C. Yang, MD, MPH3*, Timothy J. Robinson, MD, PhD2*, Michael D. Jain, MD, PhD2, Amit Maity, MD, PhD1*, Ima Paydar, MD5*, Yolanda D. Tseng, MD, MPhil4*, Steve E. Braunstein, MD, PhD3*, Stephen J. Schuster, MD1, Elise A. Chong, MD1 and John P. Plastaras, MD, PhD5*

1University of Pennsylvania, Philadelphia, PA
2H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
3University of California San Francisco, San Francisco, CA
4University of Washington, Seattle, WA
5Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA

Faith O Abodunrin, MD1, Oluwatayo Adeoye, MD2*, James O. Armitage, MD3, Peter Silberstein, MD4*, Oluwasegun Akinyemi, MD5* and Connor Tupper6*

1Internal Medicine, CHI Health Creighton University Medical Center, Omaha, NE
2Department of Internal Medicine, St Elizabeth's Medical Center, Boston, MA
3Division of Oncology and Hematology, University of Nebraska Medical Center- Fred & Pamela Buffett Cancer Center, Omaha, NE
4Department of Medicine, Creighton University Medical Center, Omaha, NE
5The Clive O. Callender Outcomes Research Center, Howard University College of Medicine, Macomb, IL
6Creighton University School of Medicine, Omaha

Mengyang Di, MD, PhD1,2, Jessica B Long, MPH1*, Shalin K. Kothari, MD3, Tarsheen Sethi, MD, MBBS, MSc3, Amer M. Zeidan, MD1,3, Nikolai A. Podoltsev, MD, PhD1,3, Rory M. Shallis, MD1,3, Rong Wang, PhD1,4*, Jessica M. Stempel, MD2, Xiaomei Ma, PhD1,4* and Scott F. Huntington, MD, MPH1,3

1Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University School of Medicine, New Haven, CT
2Department of Internal Medicine, Hematology/Oncology, Yale University School of Medicine, New Haven, CT
3Department of Internal Medicine, Section of Hematology, Yale University School of Medicine, New Haven, CT
4Department of Chronic Disease Epidemiology, Yale University School of Public Health, New Haven, CT

Rishab Prakash, BS1*, James Long, PhD2*, Paul Edelkamp Jr.3*, Mark Knafl3*, Sairah Ahmed, MD4, Fareed Khawaja, MBBS5, Loretta J. Nastoupil, MD1, Joanna-Grace Manzano, MD3*, Victor Mulanovich, MD3*, Sabitha Prabhakaran, PhD3*, Andrew Futreal, PhD6*, Scott E Woodman, MD, PhD3* and Swaminathan Padmanabhan Iyer, MD1*

1Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Biostatistics, MD Anderson Cancer Center, Houston
3UT MD Anderson Cancer Center, Houston, TX
4Department of Lymphoma/Myeloma and Stem Cell Transplantation, MD Anderson Cancer Center, Houston, TX
5Department of Infectious Diseases, MD Anderson Cancer Center, Houston, TX
6Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Melissa F. Miller, PhD*, Erica E. Fortune, PhD*, Kimberly Papay Rogers, PhD* and Alexandra K. Zaleta, PhD*

Research and Training Institute, Cancer Support Community, Philadelphia, PA

Xiaoqin Yang, PhD1*, Enrico Zanardo2*, Dominique Lejeune3*, Enrico De Nigris1*, Eric Sarpong, PhD1*, Mohammed Z.H. Farooqui, DO1 and François Laliberté3*

1Merck & Co., Inc., Rahway, NJ
2Analysis Group, Inc., Denver, CO
3Groupe d’analyse, Ltée, Montréal, QC, Canada

Laura B. Oswald, PhD1*, Yi Luo, PhD2*, Xiaoyin Li, PhD1*, Aasha I. Hoogland, PhD1*, Brian D. Gonzalez, PhD1*, Doris K. Hansen, MD3, Michael D. Jain, MD, PhD3, Frederick L. Locke, MD4, Lauren C. Peres, PhD, MPH5*, Kedar Kirtane, MD6*, Issam El Naqa, PhD2* and Heather S. L. Jim, PhD1*

1Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL
2Department of Machine Learning, Moffitt Cancer Center, Tampa, FL
3Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL
4H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
5Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL
6Department of Head and Neck-Endocrine Oncology, Moffitt Cancer Center, Tampa, FL

Faiz Anwer, MD1, Debbie Goldschmidt, PhD2*, Wenxi Tang, MS2*, David R. Steffen, BA2*, Binyam Yilma, MPH2* and Samantha Slaff, MS3*

1Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
2Analysis Group, Boston, MA
3Bristol Myers Squibb, Princeton, NJ

Ana Carolina Oliver, MD1,2, Luis Mario Villela Martinez, MD, MSc3,4*, María Victoria Irigoín, MD2,5*, María Lorena Cardozo, MD6*, Seisha Alana Von Glasenapp Gossen7*, Macarena Alejandra Roa Salinas, MD8*, Marialejandra Alejandra Torres Viera, MD9,10*, Virginia Lema, MD11*, Denisse Castro, MD12, Jose Alvarez, MD13*, Fernando Perez-Jacobo, MD14*, Arianna Robles, MD15*, Melani Otañez, MD16*, Camila Peña, MD17, Virginia Bradvica, MD18*, Sally Rose Paredes, MD19*, Guilherme Fleury Perini, MD20*, Henry Idrobo, MD21*, Brady E Beltran, MD12*, Luis Enrique Malpica Castillo, MD22,23 and Jorge J. Castillo, MD24

1Hematology Department, British Hospital, Montevideo, Uruguay
2CASMU, Montevideo, Uruguay
3Escuela de Medicina Del Tecnológico de Monterrey, Hermosillo, SO, Mexico
4Servicio de hematología, Centro Medico Dr. Ignacio Chavez del ISSSTESON, Hermosillo, SO, Mexico
5COSEM, Montevideo, Uruguay
6Hematology Service, Hospital Central del Instituto de Previsión Social, Asuncion, Paraguay
7Department of Hematology, Instituto de Prevision Social, Asuncion, Paraguay
8Hematología, Hospital Del Salvador, Santiago, Chile
9Universidad Central de Venezuela, Caracas, Venezuela (Bolivarian Republic of)
10Clinica Santa Sofia, Caracas, Miranda, Venezuela
11Hospital Central de las Fuerzas Armaddas, Montevideo, Uruguay
12Departamento de Oncología y Radioterapia, Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru
13Hemtology, Centro Médico Nacional 20 Noviembre, Mexico City, Mexico
14Hematology and blood bank services, Hospital Central Norte PEMEX, CDMX, Mexico
15Universidad de Guadalajara, CUCS, HGO, Zapopan, MEX
16Hospital General del Estado de Sonora, Hermosillo, SO, Mexico
17Hematology Department, Hospital Del Salvador, Santiago, Chile
18Hospital Central de las Fuerzas Armadas, Montevideo, Uruguay
19Centro de Investigacion de Medicina de Precision, Universidad de San Martin de Porres, LIMA, Peru
20Hospital Israelita Albert Einstein, Sao Paulo, PA, Brazil
21Facultad de Medicina., Universidad Del Valle, Cali, Colombia
22Hematology/Oncology, UNC, Pearland, TX
23The University of Texas MD Anderson Cancer Center, Houston, TX
24Dana Farber Cancer Institute, Boston, MA

Ashley Saunders, MPH, MSc, PharmD1*, Sushmitha Inguva, MS, PhD2*, Scott J Keating, MS1* and Viktor Chirikov, MS, PhD2*

1Bristol Myers Squibb, Princeton, NJ
2OPEN Health, Bethesda, MD

Christine Mazimba, DNP, MPH1*, Kiarash Salafian, MD2*, Leonid Volodin, MD3, Asal Pilehvari, Ph.D2*, Wen You, Ph.D2* and Karen K. Ballen, MD4

1UVA Health, Charlottesville, VA
2UVA Health, Charlottesville
3Division of Hematology/Oncology, UVA Health, Charlottesville, VA
4Division of Hematology/Oncology, University of Virginia Health Center, Charlottesville, VA

Rajshekhar Chakraborty, MBBS1, Tapas Ranjan Behera2*, Hong Li, MS3*, Robert M. Dean, MD4, Brian T. Hill, MD, PhD4, Deepa Jagadeesh, MD4, Allison Winter, MD4, Faiz Anwer, MD5, Brad Pohlman, MD4, Ronald M. Sobecks, MD4, Betty K. Hamilton, MD6 and Navneet S. Majhail, MD7

1Hematology and Oncology, Columbia University Medical Center, New York, NY
2Taussig Cancer Center, Cleveland Clinic, Cleveland
3Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH
4Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
5Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
6Cleveland Clinic Foundation, Cleveland, OH
7Sarah Cannon, Nashville, TN

Claire Fraley, MD1*, Jamie Neiman, PhD1*, Charlotte Feddersen, MD, PhD2*, Claire James3*, Taylor Jones, MD2*, Margit Mikkelsen, MD2*, Kristen Miller, MS2*, Paige Dillon4*, Amanda C. Winters, MD, PhD4, Alyssa M Schlenz, PhD5*, Rachelle Nuss, MD1*, Adam L. Green, MD1* and Bruce E. Compas, PhD6*

1Center for Cancer and Blood Disorders, University of Colorado Anschutz Medical Campus, Aurora, CO
2Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO
3Carleton College, Northfield, MN
4University of Colorado Anschutz Medical Campus, Aurora, CO
5University of Colorado School of Medicine/Children's Hospital Colorado, Aurora, CO
6Department of Psychology and Human Development, Vanderbilt University, Nashville, TN

Yuliya Linhares, MD1*, Fei Fei Liu, BSc, MBA2*, Cesar Freytes, MD3, Mohamad Cherry, MD, MS4, Ling Shi, PhD5*, Weiqin Liao, MPH5*, Julia Braverman, PhD2*, Ricardo Espinola, MD6*, Min Vedal, PhD7* and Bassam Mattar, MD, FACP8*

1Blood and Marrow Transplant Program, Miami Cancer Institute, Baptist Health, Miami, FL
2Bristol Myers Squibb, Princeton, NJ
3Sarah Cannon Transplant & Cellular Therapy Program at Methodist Hospital, San Antonio, TX
4Atlantic Health System, Carol Simon Cancer Center, Morristown, NJ
5Evidera, Waltham, MA
6Bristol Myers Squibb, San Diego, CA
7Bristol Myers Squibb, Seattle, WA
8Cancer Center of Kansas, Wichita, KS

Xiaoqin Yang, PhD1*, Enrico Zanardo2*, Dominique Lejeune3*, Enrico De Nigris1*, Eric Sarpong, PhD1*, Mohammed Z.H. Farooqui, DO1, Sidney M. Donzella1* and François Laliberté3*

1Merck & Co., Inc., Rahway, NJ
2Analysis Group, Inc., Denver, CO
3Groupe d’analyse, Ltée, Montréal, QC, Canada

Gilles Salles, MD, PhD1, Anthony Wang, PhD, MPH2*, Alex Mutebi, PhD3*, Abualbishr Alshreef, MPH, MSc, PhD2*, Kalatu R. Davies, PhD2*, Gijs van de Wetering, PhD4* and Viktor Chirikov, MS, PhD5*

1Memorial Sloan Kettering Cancer Center, New York, NY
2AbbVie, Inc., North Chicago, IL
3Genmab, Princeton, NJ
4Open Health, Bethesda, MD
5OPEN Health, Bethesda, MD

Stefanie Thiel1*, Karin Melanie Cabanillas Stanchi, Dr.1*, Johanna Xemaire2*, Dustin Werle3*, Jennifer Svaldi, Dr.3*, Stefanie Joachim, Dr.1*, Peter Lang, Dr.1*, Rupert Handgretinger, Dr.1 and Michaela Döring, Dr.1*

1Dpt. I - General Pediatrics, Hematology and Oncology, University Children's Hospital Tübingen, Tübingen, Germany
2Tübinger Akademie für Kinder- und Jugendlichenpsychotherapie GmbH, Tübingen, Germany
3Clinical Psychology and Psychotherapy, University of Tübingen, Tübingen, Germany

Kelly S. Chien, MD1, Christine B. Peterson, PhD2*, Elliana Young, MS3*, Dai Chihara, MD4, Elisabet E. Manasanch, MD4, Jeremy L. Ramdial, MD5 and Philip A. Thompson, MBBS1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, TX
3Department of Enterprise Data Engineering & Analytics, The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
5Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX

Jorge Arturo Hurtado Hurtado Martinez, MD*, Nathan W. Sweeney, PhD, David F. Barton, BA MPA MBA*, Jennifer M. Ahlstrom, BA* and Jay R. Hydren, PhD*

HealthTree Foundation, Lehi, UT

Jason N Barreto, PharmD1, Erin F Barreto, PharmD1*, Kristin C. Mara, MS2*, Andrew D. Rule, MD3*, Marissa Z. Powell, PharmD1*, Radhika Bansal, MBBS4*, Matthew A. Hathcock, M.S.5*, Sandra M. Herrmann, MD3*, Adrienne N. Nedved, PharmD1*, Stephen M. Ansell, MD, PhD4, N. Nora Nora Bennani, MD4, Jonas Paludo, MD6, Patrick B. Johnston, MD, PhD7, Urshila Durani, MD, MPH7, Tyler B. Sandahl, PharmD1*, Yucai Wang, MD, PhD6, Arushi Khurana, MBBS4, Hassan B. Alkhateeb, MD4*, Mithun V. Shah, MD, PhD4, Prashant Kapoor, MD7, Morie A Gertz, MD8, Shaji K Kumar, MD7, David Dingli, MD, PhD4, Taxiarchis Kourelis, MD4, Rahma M Warsame, MD7, Suzanne R. Hayman, MD4, Nelson Leung, MD9 and Yi Lin, MD, PhD7

1Department of Pharmacy, Mayo Clinic, Rochester, MN
2Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
3Division of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic, Rochester, MN
4Division of Hematology, Mayo Clinic, Rochester, MN
5Department of Biostatistics, Mayo Clinic, Rochester, MN
6Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
7Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
8Division of Hematology, Department of Internal Medicine, Mayo Clinic, ROCHESTER, MN
9Division of Hematology, Mayo Clinic, Rochester, Rochester, MN

Rebecca S Parker, MD1, Justin Le, BS2*, Miguel Villa1*, Maurice R.G. O'Gorman, PhD3,4*, Jennifer Dien-Bard, PhD5*, Seon-Jae Yoon4*, Yesun Lee6*, Andrew Doan, MD1,7*, Paibel Aguayo-Hiraldo, MD8*, Pia Pannaraj, MD6* and Chintan Parekh, MBBS9

1Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Los Angeles, CA
2Cancer and Blood Disease Institute, Children’s Hospital Los Angeles, Los Angeles, CA
3Children's Hospital Los Angeles, Los Angeles, CA
4University of Southern California, Los Angeles, CA
5Clinical Microbiology and Virology Laboratory, Children's Hospital Los Angeles, Los Angeles, CA
6Infectious Diseases, Children's Hospital Los Angeles, Los Angeles, CA
7Keck School of Medicine, University of Southern California, Los Angeles, CA
8Cancer and Blood Disease Institute, Children's Hospital of Los Angeles, Los Angeles, CA
9Division of Hematology and Oncology, Department of Pediatrics, Children's Hospital of Los Angeles, University of Southern California, Los Angeles, CA

November McGarvey, PhD, MPH1*, Thomas Carattini, PharmD, MBA2*, Brian Ung, MS, PharmD2*, Timothy B. Campbell, MD, PhD**2, Ken Imanak, PhD, MA1* and Pallavi Patwardhan, PhD, BSPharm2*

1BluePath Solutions, Los Angeles, CA
2Bristol Myers Squibb, Princeton, NJ

Angelica D'Aiello, MD1, Sumaira Zareef, MD2*, Eleftheria Atalla, MD3*, Ahmed Abbasi, MD4*, Kith Pradhan, PhD4*, Amanda Lombardo, PA-C, BS, MS5*, Fariha Khatun, PA-C5*, Jennat Mustafa, PA-C2*, Alyssa De Castro, PharmD1*, Felisha Joseph, PA-C5*, Kailyn Gillick, PA-C5*, Astha Thakkar, MBBS6, Lauren C Shapiro, MD1, Shafia Rahman, MD5, Zhu Cui, MD1*, Jesus D Gonzalez Lugo, MD1*, Fiona Mienko, MBBS1, Numa Rahman, MD1*, Robert Lopez, MD1, Heidi Chwan Ko, DO1, Amanda Podolski, MD1, Vikas Mehta, MD7*, Sanjay Goel, MD1*, Rafi Kabarriti, MD8*, Joseph Sparano, MD1*, Stuart Packer, MD1*, David Lawrence Fernandes, MD1*, Enrico Castelucci, MD1*, Margarita Kushnir, MD1, Mark Chaitowitz, MD9, Luca Paoluzzi, MD1*, Ulrich G. Steidl, MD, PhD10, Phaedon Zavras, MD3*, Dennis Cooper, MD10, Marina Konopleva, MD1*, Balazs Halmos, MD1*, Ioannis Mantzaris, MD1, Noah Kornblum, MD11*, Aditi Shastri, MD12, Lizamarie Bachier-Rodriguez, MD1*, Kira Gritsman, MD, PhD1, Henny H. Billett, MD MSc13, Rachel Bartash, MD14*, Yoram Puius, MD, PhD14*, Margaret McCort, MD14*, Ira Braunschweig, MD15, Mendel Goldfinger, MD1, Amit Verma, MD, MBBS16* and R. Alejandro Sica, MD1

1Hematology/Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
2Montefiore Medical Center Center for Cancer Care, Bronx, NY
3Jacobi Medical Center, Bronx, NY
4Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
5Montefiore Medical Center/ Albert Einstein College of Medicine, Bronx, NY
6Department of Oncology, Montefiore Medical Center Center for Cancer Care, Bronx, NY
7Otolaryngology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
8Radiation Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
9Hematology/Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, New York, NY
10Department of Oncology, Montefiore Medical Center/ Albert Einstein College of Medicine, Bronx, NY
11Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
12Oncology, Hematology/Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
13Hematology/Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx
14Infectious Disease, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
15Hematology/Oncology, Montefiore Medical Center/ Albert Einstein College of Medicine, Bronx, NY
16Department of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY

Justin Gatwood, PhD, MPH1*, Ankur Dashputre, PhD2*, Abhijeet Rajpurohit, MS3*, Katie S. Gatwood, PharmD4*, Emily Mackler, PharmD5*, Karen Farris, PhD6*, Amna Rizvi-Toner, PharmD6* and Joel Farley, PhD7*

1College of Pharmacy, The University of Tennessee Health Science Center, Nashville, TN
2University of Tennessee Health Science Center, Memphis, TN
3Department of Pharmaceutical Care and Health Systems, University of Minnesota College of Pharmacy, Minneapolis, MN
4Department of Pharmacy, Vanderbilt University Medical Center, Nashville, TN
5Clinical Quality Initiatives Michigan Oncology Quality Consortium, Michigan Medicine, Ann Arbor, MI
6University of Michigan College of Pharmacy, Ann Arbor, MI
7University of Minnesota College of Pharmacy, Minneapolis, MN

Esteban Toro Velez, MD1, Lauren Diaz Boyle, DO1*, Qianqian Liu, PhD2*, Joel E Michalek, PhD2* and Adolfo Enrique Diaz Duque, MD3

1Mays Cancer Center, University of Texas Health Science Center at San Antonio, San Antonio, TX
2Department of Epidemiology and Biostatistics, University of Texas Health Science Center at San Antonio, San Antonio, TX
3Hematology-Oncology Division, Associate Professor, San Antonio, TX

Reem Karmali, MD, MSc1, Narendranath Epperla, MD, MS2, Geoffrey Shouse, PhD, DO3, Jason T. Romancik, MD4, Tamara K. Moyo, MD, PhD5*, Vaishalee P. Kenkre, MD6, Thomas A. Ollila, MD7, Lindsey A. Fitzgerald, MD8, Brian T. Hess, MD9, Andrew M. Evens, DO, MBA, MMSc10, Ishan Roy11*, Joanna Zurko, MD12, Sayan Mullick Chowdhury, DO, PhD13*, Kaitlin Annunzio, DO14, Robert Ferdman, MD15*, Rahul Bhansali, MD16*, Elyse I. Harris, MD17, McKenzie Sorrell, DO9, Jieqi Liu, MD18, Imran A. Nizamuddin, MD19, Shuo Ma, MD20, Jonathan Moreira, MD21, Jane N. Winter, MD22, Barbara Pro, MD22,23, Deborah M. Stephens, DO24, Alexey V Danilov, MD25, Nirav N. Shah, MD26, Jonathon B. Cohen, MD, MS27, Stefan K. Barta, MD28, Pallawi Torka, MD15 and Leo I. Gordon, MD21

1Robert H. Lurie Comprehensive Cancer Center, Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL
2The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH
3Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA
4Department of Hematology and Medical Oncology, Winship Cancer Institute at Emory University, Atlanta, GA
5Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC
6Carbone Cancer Center, University of Wisconsin, Madison, WI
7Lifespan Cancer Institute, Brown University, Providence, RI
8Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT
9Hollings Cancer Center, Medical University of South Carolina, Charleston, SC
10Rutgers Cancer Institute of New Jersey, Warren, NJ
11Northwestern University, Chicago, IL
12University of Wisconsin, Madison, WI
13Ohio State University Medical Center, Columbus, OH
14The Ohio State University, Columbus, OH
15Roswell Park Comprehensive Cancer Center, Buffalo, NY
16Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
17Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI
18Rutgers Cancer Institute of New Jersey, Hoboken, NJ
19Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL
20Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL
21Department of Medicine, Division of Hematology/Oncology and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Northwestern University Feinberg School of Medicine, Chicago, IL
22Division of Hematology and Oncology, Northwestern University, Chicago, IL
23Division of Hematology and Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL
24Huntsman Cancer Institute, Salt Lake City, UT
25Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
26Froedtert Hospital and the Medical College of Wisconsin, Milwaukee, WI
27Department of Hematology and Medical Oncology, Emory University, Atlanta, GA
28Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA

Brooke Dulka, PhD1*, Robert N. Bone, PhD1*, Yolaine Jeune-Smith, PhD1*, Muhamed Baljevic, MD2 and Bruce A. Feinberg, DO1

1Cardinal Health Specialty Solutions, Dublin, OH
2Vanderbilt University Medical Center, Nashville, TN

Seok-Goo Cho, M.D., Ph.D.1*, Jae-Cheol Jo, MD., PhD.2, Young-Woo Jeon, M.D., Ph.D.3*, Dajung Kim, M.D.4*, Deok-Hwan Yang, MD, PhD5*, Won Sik Lee, MD, PhD6, Yoon Seok Choi, MD, PhD7, Jun Ho Yi, MD8, Dok Hyun Yoon9*, Jee Hyun Kong, MD, PhD10*, Jung-yoon Choe, MD, PhD11*, Sung Hyun Kim, PhD12*, Keum Young Ahn, PhD12*, TaeHong Park12*, Jeongah Park13* and Sangeun Han, DVM, Msc12*

1Department of Hematology, Seoul St. Mary's Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
2Department of Hematology and Oncology,, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea, Republic of (South)
3Department of Hematology, Leukemia Research Institute, Yeouido St. Mary’s Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
4Division of Hematology-Oncology, Department of Internal Medicine, Kosin University College of Medicine, Kosin University Gospel Hospital, Busan, Korea, Republic of (South)
5Department of Internal Medicine, Chonnam National University Medical School, Chonnam National University Hwasun Hospital, Gwang-ju, Korea, Republic of (South)
6Department of Internal Medicine, Inje University Busan Paik Hospital, Busan, Korea, Republic of (South)
7Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Korea, Republic of (South)
8Department of Internal Medicine, Chung-ang University Hospital, Seoul, Korea, Republic of (South)
9Asan Medical Center, Seoul, Korea, Republic of (South)
10Division of Hematology-oncology, Department of Internal Medicine, Wonju College of Medicine, Yonsei University, Wonju, Korea, Republic of (South)
11Daegu catholic univ. medical center, Daegu, Korea, Republic of (South)
12Celltrion, Inc., Incheon, Korea, Republic of (South)
13Celltrion, Inc., Incheon, South Korea

Mohammad Ebad Ur Rehman, MBBS1*, Jawad Basit1*, Fatima Faraz, MBBS1*, Khawar Abbas1*, Sajeel Saeed1*, Maurish Fatima2*, Razwana Khanam, MD3*, Larabe Farrukh, MBBS4*, Usman Ali Akbar, MBBS5*, Haris Zulfiqar1*, Ahmad Iftikhar, MD6* and Faiz Anwer, MD7

1Rawalpindi Medical University, Rawalpindi, Pakistan
2Department of Medicine, King Edward Medical University, Lahore, Pakistan
3Baystate Medical Center, Springfield, MA
4Internal Medicine, Albany Medical Center, Albany, NY
5Department of Internal Medicine, Northwell Health, New York, NY
6The University of Arizona, Tucson, AZ
7Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

Adrian Alegre, MD1*, Luis Juarez-Salcedo, MD2*, Víctor Jiménez-Yuste, MD, PhD3*, Julio Garcia-Suarez4*, José Luis Díez-Martín, MD, PhD5, Joaquín Martínez-López, MD, PhD6*, Beatriz Aguado, MD7*, José Ángel Hernández-Rivas8*, Lauren Benito9*, Pilar Martinez-Barranco10*, Javier López Jiménez, MD, PhD11*, Pedro Sanchez-Godoy, MD12*, Fj Peñalver, MD10*, Alberto Velasco, MD13*, Adriana Pascual14*, Celina Benavente Cuesta15*, María Pilar Llamas Sillero, MD, PhD16*, Juan Francisco DEL Campo17*, Elena Ruiz18*, Regina Herraez, MD19*, Javier Ortiz, MD20*, Carolina Miranda21* and Gregorio Garrido22*

1Hospital Universitario de La Princesa, Madrid, Spain, Madrid, Spain
2Hospital Universitario La Princesa, Madrid, Madrid, Spain
3Hospital Universitario La Paz, Autónoma University, Madrid, Spain
4Hospital Universitario Principe de Asturias, Alcala De Henares, ESP
5Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain
6Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain
7Hospital Universitario de La Princesa, Madrid, Spain
8Hematology Department, Hospital Universitario Infanta Leonor, Madrid, Spain
9Hematology, Hospital de Getafe, Madrid, ESP
10Hematology Department, Hospital Universitario Fundación Alcorcón, Madrid, Spain
11Hematology Service, Hospital Universitario Ramón y Cajal, Madrid, Spain
12Hematology Department, Hospital Universitario Severo Ochoa, Madrid, Spain
13Hematology, Hospital Universitario Rey Juan Carlos, Madrid, Spain
14Hospital Universitario Infanta Elena, Madrid, Spain
15Department of Haematology, Hospital Clínico San Carlos. Madrid, Spain, Madrid, ESP
16Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
17Hospital Universitario del Henares, Coslada, ESP
18Hospital del Tajo, Madrid, Spain
19Hospital Universitario Infanta Sofía, Madrid, Spain
20Hospital Universitario La Princesa, Madrid, Spain
21Hospital Universitarios Rey Juan Carlos, Madrid, Spain
22Oficina de registro de Tumores de Madrid (RTMAD), Madrid, Spain

Carla Minoia, MD, PhD1*, Davide Bavaro, MD2*, Giacomo Loseto, MD3*, Crescenza Pasciolla, MD4*, Lucia Diella5*, Carmen Pelligrino, MD2*, Valentina Totaro, MD5*, Vito Spada, MD6*, Michele Camporeale, MD5*, Immacolata Attolico, MD7*, Tommasina Perrone8*, Felice Clemente, MSc3*, Francesco di Gennaro, MD PhD2*, Pellegrino Musto, MD9,10, Attilio Guarini, MD11* and Annalisa Saracino6*

1Hematology and Cell Therapy, Istituto Tumori "Giovanni Paolo II" I.R.C.C.S. Ospedale Oncologico, Bari, Italy
2Clinic of Infectious Diseases, Department of Biomedical Sciences and Human Oncology,, University of Bari "Aldo Moro", Bari, Italy
3Hematology Unit, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy
4Hematology Unit - Istituto Tumori Bari "Giovanni Paolo" IRCCS, Bari, Italy
5Clinic of Infectious Diseases, Department of Biomedical Sciences and Human Oncology, University of Bari "Aldo Moro", Bari, Italy
6Clinic of Infectious Diseases, Department of Biomedical Sciences and Human Oncology, University of Bari "Aldo Moro", Bari, Italy, University of Bari "Aldo Moro", Bari, Italy
7Hematology Unit, University of Bari, Bari, Italy
8Hematology Unit, University of Bari "Aldo Moro", Bari, Italy
9Department of Emergency and Organ Transplantation, “Aldo Moro” University School of Medicine, Bari, Italy
10Hematology and Bone Marrow Transplantation Unit - AOUC Policlinico, Department of Emergency and Organ Transplantation, “Aldo Moro” University, Bari, Italy
11Hematology and Cell Therapy Unit, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy

Olivier Decaux, MD, PhD1,2*, Radhia Lafore3*, Daniel Iaquinta, PhD, MBA3*, Christina Tekle, PhD4* and Xavier Leleu, MD, PhD5

1Université de Rennes 1, INSERM, Établissement Français du Sang de Bretagne, Unité Mixte de Recherche (UMR)_S1236, Rennes, France
2Service d'hématologie clinique, Centre Hospitalier Universitaire de Rennes, Rennes, France
3Sanofi, Gentilly, France
4Sanofi, Cambridge, MA
5Centre Hospitalo-Universitaire (CHU) La Mileterie, INSERM CIC 1402, Poitiers, France

Shakthi Bhaskar, MD1, Vivek Patel, MD1, David L. Porter, MD2, Stephen J. Schuster, MD2, Loretta J. Nastoupil, MD3, Miguel-Angel Perales, MD4,5, Ana Alarcon Tomas6,7*, Michael R. Bishop, MD8, Joseph P. McGuirk, DO9, Richard T. Maziarz, MD10, Andy Chen, MD, PhD11, Veronika Bachanova, MD, PhD12, Peter A. Riedell, MD8 and Olalekan O. Oluwole, MBBS1

1Vanderbilt University Medical Center, Nashville, TN
2Blood and Marrow Transplant and Cellular Therapy Program, Abramson Cancer Center, The University of Pennsylvania, Philadelphia, PA
3Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
4Adult Bone Marrow Transplant Service, Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
5Department of Medicine, Weill Cornell Medical College, New York, NY
6Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
7Ph.D Program in Signals Integration and Modulation in Biomedicine, Cell Therapy, and Translational Medicine, University of Murcia, University of Murcia, Murcia, Spain
8The David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL
9Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
10Knight Cancer Institute, Oregon Health and Science University, Portland, OR
11Center for Hematologic Malignancies, Knight Cancer Institute, Oregon Health and Science University, Portland, OR
12Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN

Erik Wu1*, Alexander V Stanisic, BS1*, David J. Fei-Zhang, BA1*, Marquita Lewis-Thames, MS, MPH, PhD2,3* and Sherif M. Badawy, MD1,4

1Northwestern University Feinberg School of Medicine, Chicago, IL
2Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL
3Center for Community Health, Northwestern University Feinberg School of Medicine, Chicago, IL
4Ann %26 Robert Lurie Children's Hospital, Chicago, IL

Leora S Boussi, MD1, Min Jung Koh, MS2*, Xinyi Han, BS3*, Luke Peng4*, Min Ji Koh, BA5*, Ijeoma Eche, PhD6*, Josie Germain Ford, BS5*, Shambhavi Singh, MD, PhD7*, Eliana Miranda, MEd, PhD8*, Carlos S. Chiattone, MD, PhD8, Carrie Van Der Weyden, MBBS (Hons), FRACP, FRCPA9*, Henry Miles Prince, MBBS (Hons), MD, FRACP, FRCPA, AFRCMA, MACD, FAHMS9, Francine M. Foss, MD10, Sang Eun Yoon, MD11*, Won-Seog Kim, MD, PhD12*, Girisha Panchoo, MBBS13*, Estelle Verburgh, MBChB, M Med Int, FCPSA, PhD13, Jackielyn Cuenca Alturas, BA14*, Mubarak Al-mansour, MD15*, Martina Manni, PhD16*, Massimo Federico, MD16, Maria Elena Cabrera, MD17*, Beatrice Casadei, MD, PhD18*, Pier Luigi Zinzani, MD, PhD19, Noriaki Yoshida, MD, PhD20, Takeshi Okatani, MD21*, Mwanasha H. Merrill, MD22, Eric D Jacobsen, MD23*, Owen A. O'Connor, MD, PhD24*, Enrica Marchi, MD, PhD24 and Salvia Jain, MD25

1Beth Israel Deaconess Medical Center, Boston, MA
2Georgetown University School of Medicine, Washington, DC
3Massachusetts Institute of Technology, Cambridge, MA
4College of Science, Northeastern University, Boston, MA
5Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA
6Dana Farber Cancer Institute, Boston, MA
7Department of Medicine, Massachusetts General Hospital, Boston, MA
8Department of Medicine, Santa Casa Medicine School, Sao Paulo, Brazil
9Department of Hematology, Peter MacCallum Cancer Center, Melbourne, Australia
10Hematology, Yale Cancer Center, New Haven, CT
11Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
12Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
13University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa
14Department of Medicine, King Abdulaziz Medical City, Jeddah, Saudi Arabia
15King Abdulaziz Medical City, Jeddah, Saudi Arabia
16Surgical, Medical and Dental Department of Morphological Sciences related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy
17Hematology Department, Hospital del Salvador, Santiago, Chile
18Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology L. e A. Seràgnoli, University of Bologna, Bologna, Italy
19IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seragnoli”Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale Università di Bologna, Bologna, Italy
20Radiation Effects Research Foundation, Hiroshima-Shi, Japan
21Department of Hematology, Hiroshima Red Cross Hospital and Atomic-bomb Survivors Hospital, Hiroshima, Japan
22Dana Farber Cancer Institute, boston, MA
23Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
24Program for T-Cell Lymphoma Research, University of Virginia, Charlottesville, VA
25Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA

Akiva Diamond, MD1, Wyatt P. Bensken, PhD2*, Long Vu, MS2*, Siran M. Koroukian, PhD2* and Paolo F. Caimi, MD3,4

1Dan L Duncan Comprehensive Cancer Center at Baylor St. Luke's Medical Center, Houston, TX
2Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH
3Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH
4Blood and Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH

David K. Buchbinder, MD, MSHS1,2, Neel S. Bhatt, MBBS, MPH3,4, Huiqi Wang, MS5*, Yutaka Yasui, PhD5*, Saro H. Armenian, DO, MPH6, Smita Bhatia, MD, MPH7, Eric J. Chow, MD, MPH3,4*, I-Chan Huang, PhD5*, Anne C. Kirchhoff, PhD, MPH8,9*, Wendy Leisenring, ScD3*, K. Robin Yabroff, PhD10*, Gregory T. Armstrong, MD, MSCE5*, Paul Nathan, MD11,12* and Nandita Khera, MD, MPH13

1Department of Pediatrics, University of California at Irvine, Irvine, CA
2Division of Hematology/ Oncology, Children’s Hospital of Orange County, Orange, CA
3Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
4Department of Pediatrics, Division of Hematology/Oncology, University of Washington School of Medicine, Seattle, WA
5Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN
6Department of Pediatrics, City of Hope Comprehensive Cancer Center, Duarte, CA
7Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
8Division of Health System Innovation and Research, Huntsman Cancer Institute, Salt Lake City, UT
9Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT
10Surveillance and Health Equity Science, American Cancer Society, Atlanta, GA
11Division of Haematology/Oncology, Hospital For Sick Children, Toronto, ON, Canada
12Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada
13Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ

Michael Fradley1*, Marie-Hélène Lafeuille, MA2*, Bruno Emond, MSc2*, Samuel Crawford, MSc3*, Naijun Chen, PhD3*, Raisa Volodarsky, PharmD3*, Jacqueline Nielsen, PhD4* and Bhavini Patel Srivastava, MSc3*

1Hospital of the University of Pennsylvania, Perelman School of Medicine, Thalheimer Center for Cardio-Oncology, Abramson Cancer Center and Division of Cardiology, Philadelphia, PA
2Analysis Group, Inc., Montreal, QC, Canada
3AbbVie, Inc., North Chicago, IL
4Pharmacyclics LLC, an AbbVie Company, South San Francisco, CA

Michael J. Andersen Jr., MD1*, Poorva Bindal, MD2, Phillip Michaels, MD3, Pavania Elavalakanar, MSc, BSc2*, Ajoy L. Dias, MD4, Jon E. Arnason, MD1 and Rushad Patell, MBBS1

1Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
2Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
3Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
4Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA

Sergio Ramos-Cillan1*, Natalia Barreras Ruiz2*, Adriana Pascual1*, Eva Castillo Bazan2*, Miriam Riesco Ovelar3*, Celia Urrutia3*, Antonio Herrero4*, Susana Cruz5*, Alberto Pardo6*, Alberto Lopez-Garcia7*, Maria Angeles Perez-Saenz1*, Daniel Murillo1*, María Pilar Llamas Sillero1*, Javier Becares2*, Carla Barriocanal8*, Marta del Olmo8*, Jorge Short Apellaniz8*, Javier Arcos Campillo8* and Raul Cordoba, MD, PhD9

1Department of Hematology, Fundacion Jimenez Diaz University Hospital, Madrid, Spain
2Department of Pharmacy, Fundacion Jimenez Diaz University Hospital, Madrid, Spain
3Oncohealth Institute, Fundacion Jimenez Diaz University Hospital, Madrid, Spain
4Information and Communication Technology (ICT) Department, Fundación Jiménez Díaz University Hospital, Madrid, Spain
5ICT Department, Fundacion Jimenez Diaz University Hospital, Madrid, Spain
6Information and Communication technology (ICT) department., Fundacion Jimenez Diaz University Hospital, Madrid, Spain
7Department of Hematology, Health Research Institute IIS-FJD, Fundacion Jimenez Diaz University Hospital, Madrid, Spain
8Clinical and Organizational Innovation Unit (UICO); QUIRONSALUD PUBLIC HOSPITALS NETWORK, Madrid, Spain
9Lymphoma Unit, Department of Hematology, Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain

Tejaswini Dhawale, MD1,2, P. Connor Johnson, MD1,2*, Mahmoud R. Gaballa, MD1,2, Ashley Nelson, PhD1,2*, Mitchell W. Lavoie1*, Matthew Frigault, MD, MS1,2, Kofi Boateng1*, Claire Greydanus1* and Areej El-Jawahri, MD1,2

1Massachusetts General Hospital, Boston, MA
2Harvard Medical School, Boston, MA

*signifies non-member of ASH